Due to the nature and size of our market, the number of our patients is very limited – and so is the number of drugs on the market.

This means that we have a very vocal and engaged patient base that needs an individual and thought out approach.

In this presentation you will learn:

• How to create an individual patient-centric approach?
• How to establish who KOLs are and work with them?
• How to navigate the public debate?
• How to navigate price containment measures in the markets like CEE?